Cardiovascular disease Circulatory System Peripheral vascular disease, unspecified
Conditions
Interventions
Walking test with NWP, Same as walking test. Walking tests, Weeks 0,4,8,12. HR, ABPI, CD, MWD, Borg Pain and RPE
The only intervention we use is a pair of walking poles..randomly allocated to each patient. Each patient is followed for 12 weeks.
Ankle Brachial Pressure Index (ABPI) measured before and after ea
Visit 0, Base line tests:
Weight, heightm resting heart rate, ABPI using Doppler, max walking distance, claudication distance, Borg pain scale, and Borg RPE.
Consent
Teach NWP technique
Familiarisati
Sponsors
Sheffield Teaching Hospitals NHS Trust (UK)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients must have stable intermittent claudication due to peripheral arterial disease of more than 6/12 duration of symptoms 2. A resting ABPI of <0.9, which is unsuitable for revascularisation 3. Patient has not had a revascularisation procedure in the last six months 4. Level(s) of disease and unsuitability for revascularisation will have been previously determined by duplex ultrasound and/or magnetic resonance (MR) arteriography. 5. Patients must not have other conditions that could limit their walking distance (e.g. breathlessness or severe osteoarthrosis) or the ability to hold poles 6. Male and female participants 7. Aged between 50 - 100 years
Exclusion criteria
Exclusion criteria: 1. Patients with intermittent claudication due to peripheral arterial disease of less than 6/12 duration of symptoms 2. A resting ABPI of >0.9, which is suitable for revascularisation 3. Patient has had a revascularisation procedure in the last six months 4. Level(s) of disease and unsuitability for revascularisation will have been previously determined by duplex ultrasound and/or MR arteriography 5. Patients with other conditions that could limit their walking distance (e.g. breathlessness or severe osteoarthrosis) or problems using their hands which might affect the ability to hold poles
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Is the technique of using NPW is more effective in improving walking distance than normal walking? Measured on each patient at week 0 and 12. At week 4, and 8 we will also be recording the patient's progress using the primary outcome measures, distance walked, level of perceived exertion and level of pain at CD and MWD. | — |
Secondary
| Measure | Time frame |
|---|---|
| Compare compliance, the cardiovascular training effect, ABPI and any weight loss. Measured on each patient at week 0 and 12. At week 4, and 8 we will also be recording the patient's progress using the primary outcome measures, distance walked, level of perceived exertion and level of pain at CD and MWD. | — |
Countries
United Kingdom
Outcome results
None listed